DrugPatentWatch Database Preview
Drugs in Development Information for PSN-632,408
What is the development status for investigational drug PSN-632,408?
PSN-632,408 is an investigational drug.
There have been 6 clinical trials for PSN-632,408.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Osteoarthritis. The leading clinical trial sponsors are Sanofi, University of Pisa, and Attikon Hospital.
Summary for PSN-632,408
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 82 |
| WIPO Patent Applications | 58 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-02-01) |
| Vendors | 24 |
Recent Clinical Trials for PSN-632,408
| Title | Sponsor | Phase |
|---|---|---|
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | University of Alberta | N/A |
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | University of Toronto | N/A |
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | Western University, Canada | N/A |
Clinical Trial Summary for PSN-632,408
Top disease conditions for PSN-632,408
Top clinical trial sponsors for PSN-632,408
US Patents for PSN-632,408
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
